Why the study?
Does enalapril or losartan prevent endothelial dysfunction in a rat model of early-stage renal hypertension?
Does enalapril or losartan prevent endothelial dysfunction in a rat model of early-stage renal hypertension?
Angiotensin II receptor antagonism or ACE inhibition normalizes endothelial dysfunction in the early stages of renal hypertension in a rat model.
Answers are grounded in this paper and cite their sources.
May warrant investigation in human renal hypertension; leaves open translation beyond this rat model.
The degree of involvement of the renin-angiotensin system in endothelial dysfunction was investigated by using a one-kidney, one-clip (1K,1C) model of renal hypertension. Male Wistar rats received 0.02% enalapril, 0.02% losartan, or tap water for 1 day before and for 48 h after the induction of renal artery stenosis or sham operation. The aorta of 1K,1C rats showed increased contraction and decreased relaxation responses produced by norepinephrine and acetylcholine, respectively, vs. control responses. Exposure to 10(-5) mol/l NG-monomethyl-L-arginine acetate augmented the contractile responses to norepinephrine to a greater extent in control rats than in the 1K,1C rats. The increased contraction and decreased relaxation responses to these agonists in the 1K,1C rats were normalized by enalapril or losartan. The addition of HOE-140 to the bath did not alter these normalized responses. Results suggest that angiotensin II causes endothelial dysfunction and reduces nitric oxide levels in 1K,1C rats. Such endothelial dysfunction enhanced the norepinephrine-induced contraction during the early-stage hypertension in 1K,1C rats.
No takes yet. Share an insight, caveat, or question.
Hoshino et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: